In addition, PPARδ agonist GW7042, which is almost identical to GW501516 in structure, potency, and specificity, was inactive in inducing gene expression in PPARδ knockout mice [49], suggesting that the tumor promoting effects of GW501516 and GW7042 are not due to off-target effects. Here, PPARD is linked to neoplasm.